ES2482666B1 - Uso de la cepa CECT 7426 para provocar quorum quenching de la señal autoinductor-2 (AI-2) - Google Patents

Uso de la cepa CECT 7426 para provocar quorum quenching de la señal autoinductor-2 (AI-2) Download PDF

Info

Publication number
ES2482666B1
ES2482666B1 ES201231552A ES201231552A ES2482666B1 ES 2482666 B1 ES2482666 B1 ES 2482666B1 ES 201231552 A ES201231552 A ES 201231552A ES 201231552 A ES201231552 A ES 201231552A ES 2482666 B1 ES2482666 B1 ES 2482666B1
Authority
ES
Spain
Prior art keywords
cause
quorum quenching
auto
strain cect
signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201231552A
Other languages
English (en)
Other versions
ES2482666A1 (es
Inventor
Ana María Otero Casal
Manuel Romero Bernárdez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
Original Assignee
Universidade de Santiago de Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela filed Critical Universidade de Santiago de Compostela
Priority to ES201231552A priority Critical patent/ES2482666B1/es
Priority to PCT/ES2013/070662 priority patent/WO2014057151A1/es
Publication of ES2482666A1 publication Critical patent/ES2482666A1/es
Application granted granted Critical
Publication of ES2482666B1 publication Critical patent/ES2482666B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Uso de la cepa CECT 7426 para provocar quorum quenching de la señal Autoinductor-2 (AI-2).#La invención se refiere al uso de una cepa bacteriana de la especie Tenacibaculum discolor, del extracto celular crudo o del sobrenadante de sus cultivos, para provocar quorum quenching en bacterias a través de la inhibición de señales tipo AI-2, y más concretamente para el tratamiento y/o prevención de enfermedades infecciosas y para inhibir la formación de biofilms, producidos por dichas bacterias.

Description



imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18

Claims (1)



  1. imagen1
    imagen2
ES201231552A 2012-10-09 2012-10-09 Uso de la cepa CECT 7426 para provocar quorum quenching de la señal autoinductor-2 (AI-2) Active ES2482666B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201231552A ES2482666B1 (es) 2012-10-09 2012-10-09 Uso de la cepa CECT 7426 para provocar quorum quenching de la señal autoinductor-2 (AI-2)
PCT/ES2013/070662 WO2014057151A1 (es) 2012-10-09 2013-09-23 Uso de la cepa cect 7426 para provocar quorum quenching de la señal autoinductor-2 (ai-2)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201231552A ES2482666B1 (es) 2012-10-09 2012-10-09 Uso de la cepa CECT 7426 para provocar quorum quenching de la señal autoinductor-2 (AI-2)

Publications (2)

Publication Number Publication Date
ES2482666A1 ES2482666A1 (es) 2014-08-04
ES2482666B1 true ES2482666B1 (es) 2015-05-12

Family

ID=50476966

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201231552A Active ES2482666B1 (es) 2012-10-09 2012-10-09 Uso de la cepa CECT 7426 para provocar quorum quenching de la señal autoinductor-2 (AI-2)

Country Status (2)

Country Link
ES (1) ES2482666B1 (es)
WO (1) WO2014057151A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108452667A (zh) * 2018-05-14 2018-08-28 大江环境股份有限公司 一种包含涅氏短状杆菌的生物活性填料

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108753646B (zh) * 2018-06-12 2021-10-22 上海交通大学医学院附属仁济医院 一株对革兰阳性耐药菌具有广谱抗菌活性的人葡萄球菌及其筛选方法和应用
CN110012941B (zh) * 2019-05-23 2022-07-15 光明乳业股份有限公司 一种由类芽孢杆菌制备发酵豆浆的方法及其制备出的发酵豆浆与应用
CN111419829B (zh) * 2020-03-02 2023-08-18 东北农业大学 和厚朴酚在抑制猪链球菌或其生物被膜中的用途
CN113368137B (zh) * 2021-05-06 2023-08-18 华南农业大学 一种天然的细菌群体感应抑制剂及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427408B2 (en) * 2002-06-06 2008-09-23 The Regents Of The University Of California Quorum sensing and biofilm formation
ES2342807B2 (es) * 2008-08-01 2011-03-18 Universidade De Santiago De Compostela Uso de bacterias del genero tenacibaculum para quorum quenching.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108452667A (zh) * 2018-05-14 2018-08-28 大江环境股份有限公司 一种包含涅氏短状杆菌的生物活性填料

Also Published As

Publication number Publication date
ES2482666A1 (es) 2014-08-04
WO2014057151A1 (es) 2014-04-17

Similar Documents

Publication Publication Date Title
ES2482666B1 (es) Uso de la cepa CECT 7426 para provocar quorum quenching de la señal autoinductor-2 (AI-2)
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
CR20150491A (es) 3-pirimidin-4-il oxazolidin -2- onas como inhibidores de idh mutante
ECSP14017584A (es) Compuestos inhibidores de raf
ECSP12012310A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
CR20150078A (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
GT201400009A (es) 4-imidazopiridazin-1-il-benzamidas y 4-imidazotriazin-1-il-benzamidas como inhibidores de btk
UY34445A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
CO6280490A2 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
UY33937A (es) Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
CO7020867A2 (es) Formulaciones de anticuerpo y metodos
CL2014000470A1 (es) Compuestos derivados del acido 2-oxo-piridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para tratar o mejorar una infeccion bacteriana.
NZ630800A (en) Methods of preparing substituted nucleotide analogs
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
CL2013003372A1 (es) Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes.
BR112016029781A2 (pt) composições e métodos para inibir a expressão de gene de alfa-1 antitripsina
UY33665A (es) Derivado peptídico
PE20220960A1 (es) Proteinas de variantes de secuencias de aminoacidos de cry1da1 activas para lepidopteros
BR112013030554A2 (pt) forma cristalina de ciclosporina a, métodos de preparação e métodos para uso da mesma
AR090806A1 (es) Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
BR112015001175A2 (pt) cepa não patogênica f-18 de e.coli e uso da mesma
WO2016057413A3 (en) Inhibitors of lysine gingipain
CL2013001313A1 (es) Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2482666

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150512